allylprodine

Allylprodine is a synthetic opioid analgesic and an analog of prodine, first discovered by Hoffman-La Roche in 1957 during research into pethidine derivatives. It acts as a potent agonist at the μ-opioid receptor (mu-opioid receptor), with the most active stereoisomer being up to 23 times more potent than morphine. The increased potency is attributed to the allyl group, which allows for additional binding interactions within the opioid receptor site. Like other opioids, allylprodine produces effects such as analgesia and sedation but also carries risks of typical opioid side effects including nausea, vomiting, itching, and potentially fatal respiratory depression. It has no accepted medical use in most countries and is classified as a Schedule I controlled substance in the United States[1][3][5].

Other names

AlperidineAllilprodinaAllylprodinum